LCWP
GILD icon

Legacy Capital Wealth Partners’s Gilead Sciences GILD Stock Holding History

Legacy Capital Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,919
Closed -$245K – 365
2024
Q3 		$245K Buy
+2,919
New +$223K 0.05% 307
2024
Q1 		– Sell
-3,007
Closed -$244K – 197
2023
Q4 		$244K Sell
3,007
-25
-0.8% -$1.95K 0.07% 247
2023
Q3 		$227K Buy
+3,032
New +$233K 0.06% 255

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legacy Capital Wealth Partners's GILD Position: Q4 2024 in Review

Legacy Capital Wealth Partners sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 2,919 shares — an estimated $245K sold.

Legacy Capital Wealth Partners first reported a position in GILD in Q3 2023 and held it in 3 quarters. The position peaked at $245K in Q3 2024. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Legacy Capital Wealth Partners reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Legacy Capital Wealth Partners sold 2,919 Gilead Sciences shares in Q4 2024, an estimated $245K.
  • Legacy Capital Wealth Partners first reported a position in Gilead Sciences in Q3 2023 and held it in 3 quarters.
  • Legacy Capital Wealth Partners's Gilead Sciences position peaked at $245K in Q3 2024.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Legacy Capital Wealth Partners's 13F filing for Q4 2024, filed 30 Jan 2025.